Brussels, Belgium, 9th October 2018: The European League Against Rheumatism (EULAR) has issued a call to the European institutions together with the biomedical research community to make Horizon Europe a success for Europe’s long-term health. Recognition of the positive return on investment from health research and innovation is crucial, as demonstrated by a recent study showing that every Euro invested in research on rheumatic and musculoskeletal diseases delivers a return equivalent to around 25 cents year-on-year. A dedicated conference hosted by EULAR entitled ‘Bringing chronic diseases to the forefront of health innovation: From the lab to individualised health care’, is held today to mark this call and provide concrete recommendations into the policy-making process.
Read the full PRESS RELEASE here EULAR Brussels Conference October 2018 Press Release
Conference livestream
Watch the livestream on the EULAR Facebook @eular.org social media channel, or over the EULAR website: https://www.eular.org/public_affairs_brussels_conference.cfm
Social media live discussion
Follow and take part in the discussion over the EULAR Twitter account @eular_org and use the hashtag #EULARBrussels2018 to join the discussion.